Long-acting injection to prevent HIV
Around 1,000 people at risk of HIV will be offered a long-acting injection on the NHS if they cannot have tablets to protect them from the virus. The rollout of this preventative therapy will help meet the goal of eliminating HIV transmissions in the next five years. The cabotegravir injection will be available on the NHS for people who cannot have pre-exposure prophylaxis (PrEP) tablets, in the coming months., following approval by the National Institute for Health and Care Excellence.